AI-powered cancer diagnosis company raises $55M

Ibex Medical Analytics, an artificial intelligence-powered cancer diagnostics, raised $55 million in series C financing.

Advertisement

Ibex’s Galen platform integrates AI into pathologists’ workflows. The platform has gone live at Pittsburgh-based UPMC, according to a Sept. 6 Ibex news release. The Israeli company will use the funding to expand further into the U.S.

Venture capital firm 83North led the funding round. The financing brought Ibex’s total capital raised to over $100 million.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.